Log In
Print
BCIQ
Print
Print this Print this
 

TT-401

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionPeptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R) ; Glucagon (GCG)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist; Glucagon receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$255.0M

$1.0M

$240.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today